Back to Authors

Yao, Yan

0000-0002-4003-4323

Mayo Clinic

Chinese Academy of Medical Sciences & Peking Union Medical College

Citations 2

Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS) and th
Aksu, Tolga , Brignole, Michele , Biase, Luigi Di , Deharo, Jean‐Claude , Fanciulli, Alessandra , Fedorowski, Artur , Morillo, Carlos A. , Moya, Angel , Piotrowski, Roman , Sutton, Richard , Sheldon, Robert S. , Vaseghi, Marmar , Pachon, Jose C, Amin, Reshma , Gupta, Dhiraj, Magnano, M , Malik, Varun , Schauerte, Patrick, Shen, Win-Kuang, Acosta, Juan , Calo, Leonardo , Debruyne, Philippe , Di Biase, Luigi , Deharo, Jean Claude , Fanciulli, Alessandra , Fedorowski, Artur , Kulakowski, Piotr , Morillo, Carlos , Moya, Angel , Piotrowski, Roman , Stec, Sebastian , Sutton, Richard , van Dijk, J Gert , Wichterle, Dan , Tse, Hung-Fat , Yao, Yan , Sheldon, Robert , Vaseghi, Marmar , Pachon, Jose C , Scanavacca, Maurício , Tse, Hung‐Fat , Pachón-M, José Carlos , Scanavacca, Maurício , Meyer, Christian , Gupta, Dhiraj

Europace | July 30, 2024 | Volume: 26 | Issue: 8 | Pages: No page available

10.1093/europace/euae206 Get It

Abstract Cardioneuroablation has emerged as a potential alternative to cardiac pacing in selected cases with vasovagal reflex syncope, extrinsic vagally induced sinus bradycardia-arrest or atrioventricular block. The technique was first introduced decades ago, and its use has risen over the past decade. However, as with any intervention, proper patient selection and technique are a prerequisite for a safe and effective use of cardioneuroablation therapy. This document aims to review and interpret available scientific evidence and provide a summary position on the topic.
The Diagnostic Value of Cardiac Deceleration Capacity in Vasovagal Syncope
Zheng, Lihui , Sun, Wei , Liu, Shangyu , Liang, Erpeng , Du, Zhongpeng , Guo, Jingrui, Wu, Lingmin , Asirvatham, Samuel J. , Asirvatham, Samuel J , Yao, Yan

Circulation: Arrhythmia and Electrophysiology | November 16, 2020 | Volume: 13 | Issue: 12 | Pages: No page available

10.1161/circep.120.008659 Get It

Background: Increased parasympathetic activity is thought to play important roles in syncope events of patients with vasovagal syncope (VVS). However, direct measurements of the vagal control are difficult. The novel deceleration capacity (DC) of heart rate measure has been used to characterize the vagal modulation. This study aimed to assess vagal control in patients with VVS and evaluate the diagnostic value of the DC in VVS. Methods: Altogether, 161 consecutive patients with VVS (43±15 years; 62 males) were enrolled. Tilt table test was positive in 101 and negative in 60 patients. Sixty-five healthy subjects were enrolled as controls. DC and heart rate variability in 24-hour ECG, echocardiogram, and biochemical examinations were compared between the syncope and control groups. Results: DC was significantly higher in the syncope group than in the control group (9.6±3.3 versus 6.5±2.0 ms, P <0.001). DC was similarly increased in patients with VVS with a positive and negative tilt table test (9.7±3.5 and 9.4±2.9 ms, P =0.614). In multivariable logistic regression analyses, DC was independently associated with syncope (odds ratio=1.518 [95% CI, 1.301–1.770]; P =0.0001). For the prediction of syncope, the area under curve analysis showed similar values when comparing single DC and combined DC with other risk factors ( P =0.1147). From the receiver operator characteristic curves for syncope discrimination, the optimal cutoff value for the DC was 7.12 ms. Conclusions: DC>7.5 ms may serve as a good tool to monitor cardiac vagal activity and discriminate VVS, particularly in those with negative tilt table test.